Skip to Main Content

Paper Details

Twenty-four Month Outcomes in the Collaborative Ocular Tuberculosis Study (COTS)-1: Defining the "Cure" in Ocular Tuberculosis.
Ocul Immunol Inflamm
6
2020
Author NameAffiliation
Aniruddha AgarwalPostgraduate Institute of Medical Education and Research (PGIMER)
Rupesh AgrawalYong Loo Lin School of Medicine, National University of Singapore
Rupesh AgrawalNational Healthcare Group Eye Institute, Tan Tock Seng Hospital
Rupesh AgrawalSingapore Eye Research Institute
Rupesh AgrawalMoorfields Eye Hospital, NHS Foundation Trust
Ilaria TestiMoorfields Eye Hospital, NHS Foundation Trust
Dinesh Visva GunasekeranYong Loo Lin School of Medicine, National University of Singapore
Dinesh Visva GunasekeranNational Healthcare Group Eye Institute, Tan Tock Seng Hospital
Mark WestcottMoorfields Eye Hospital, NHS Foundation Trust
Mark WestcottUCL Institute of Ophthalmology
Peter McCluskeyCentral Clinical School, Save Sight Institute, the University of Sydney
Manisha AgarwalDr Shroff's Charity Eye Hospital Daryaganj
Bahram BodaghiSorbonne University
Julio J Gonz??lez-L??pezRamon Y Cajal University Hospital
Manfred ZierhutUniversity of Tuebingen
Onn Min KonChest and Allergy Clinic, St Mary's Hospital, Imperial College Healthcare NHS Trust
John H KempenHarvard Medical School
John H KempenMyungSung Christian Medical Center and MyungSung Medical School
Quan Dong NguyenByres Eye Institute, Stanford University
Carlos PavesioMoorfields Eye Hospital, NHS Foundation Trust
Vishali GuptaPostgraduate Institute of Medical Education and Research (PGIMER)
  • 1 - 21

Datasets